chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ACUTE HYPOXEMIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE 11/5/2022,  2/9/2023,  1/7/2023,  1/26/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Sickness; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sickness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sickness). At the time of the report, ILLNESS (Sickness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment details were reported.
DVT symptoms developed on right leg on Aug 27. Went to urgent care on Sept 1. Had d-dimer which was elevated. Was sent to the ER. Had ultrasound which determined DVT present. Started on Xarelto 15mg BID for 3 weeks then Xarelto 20 mg daily for life. Consult with Hematology made.
pt recv vax JUL97 & pt was trying to get life insurance & inadvertently discovered had an inc in SGOT & SGPT levels;MD reports that the sx have resolved;
Some arm soreness initially, but about 8 hours after the injections, extreme debilitating muscle and joint soreness, fever over 100F. No treatment beyond bed rest and fluids. the most extreme pain lasted about 24 hours, gradually subsided.
Patient was here for 3 vaccination ; Varivax, Polio and MMR.  Administered Varivax first and Ipol second on pt's left arm. As soon as finishing administering Ipol, mom noticed patient was not responsive. Called EMS immediately and laid patient down on the floor. Patient's unconscious and his body seemed rigid but still breathing. Patient came back up alert 1-2 minutes after. Patient complaint of lightheadedness and vomited multiple times. Provided water and watched him carefully until medics arrive. They arrived in about 5-10 minutes, checked his vitals and advised pt to go to ER but mom refused. Informed patient to look out for severe anaphylactic symptoms and contact PCP for further evaluation and/or vaccination recommendation.
Recieved Prevnar #4, Hep A #1, and Varivax on 1/29/08.  Had lump on arm for 1 week.  Seen in our office on 2/7/08 and diagnosed with right arm cellulitis s/p Varivax vaccine.  Treated with Augmentin.
Pt tested positive for COVID after receiving both vaccines. Pt developed respiratory distress requiring supplemental oxygen.
This infant had  extreme irritability, elevated crying started within 4 - 6 hours of the immunization. No fever, she refused feedings, decreased PO intake, decreased wet diapers. Phone calls 3 thru the night. On 11/15, re-examined, 24 hours after her immunizations, nonspecific, nonfocal exam except for elevated cry and irritability. Multiple phone calls regarding fussiness, decreased PO, Tylenol, Mylicon PO attempted. On 11/16, re-examined again at 48 hours. Exam still nonspecific except irritability, mild early decrease in hydration. Status sent for labs, x-ray to r/o abdominal obstruction or sepsis. On 11/17, phone progress checked: slept through the night, took 1st full bottle 5 AM, ++ irritability.
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. No information about the patients' medical history and concurrent conditions was reported. On an unknown dates in 2017, the patients were vaccinated with improperly stored doses of PEDVAXHIB injection, lot # M034188 with expiry date 20-MAY-2019 and lot # N000235 with expiry date 26-OCT-2019 for prophylaxis. The administered doses of PEDVAXHIB underwent temperature excursion under 47-77 Fahrenheit degrees for 48 hours. There was no previous temperature excursion. Data Logger was not involved. No adverse effects were reported. The nurse reported the medical office was directed by the state officials that all of the patients, who were vaccinated with the improperly stored PEDVAXHIB, would require a revaccination. The nurse stated that she would forward all data regarding the involved patients when available. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1708USA005698: US-009507513-1707USA002480: US-009507513-1708USA005699: US-009507513-1708USA005696.
Began noticing symptoms of heart arrhythmia (fluttering, palpitating, etc.) including mild shortness of breath during workouts within several months of getting the vaccine. Was scheduled for mild outpatient procedure late November 2022 which was delayed as EKG showed heart was out of rhythm and termed "A-Flutter."  Had the cardio-version shock performed 12-21-22 to shock heart back into rhythm.   Had also started taking Tamsulosin shortly after getting vaccinated so this may have also been a contributor.   I cannot be certain as to the primary cause but never had these symptoms (arrhythmia) prior to this time frame.  My heart seems to have stayed in rhythm based upon home monitoring but still notice mild symptoms.
Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Tachycardia-Medium, Additional Details: Patient stated he had chaest tightness, palpitations, and he felt his heart throbbing.
Fever 100 degree, diarrhea, muscle aches, fatigue for 2 days
Pt vaccinated with Fluzone developed cough, nausea, headache, onset 2 days after vaccine administered advised clear liquids 24 hrs than bland diet.
2 red small blotches on chest; This is an initial spontaneous report received from Pfizer Rx Pathways from a contactable consumer (patient). A male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection Batch/Lot number was not reported, Expiration Date was not reported), via an unspecified route of administration, administered in left arm on 05Mar2021 12:30 as single dose for covid-19 immunisation. Medical history included diabetes mellitus, Allergy to Penicillin. Concomitant medications were not reported. On 07Mar2021, patient had 2 red small blotches on chest. No treatment received for the adverse event. the patient not receive any other vaccines within 4 weeks prior to the COVID vaccine; no other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient not diagnosed with COVID-19; Since the vaccination, has the patient been not tested for COVID-19. The outcome for event was reported as not resolved. The outcome of the event was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient fainted forward after receiving vaccine from seated position. patient recovered within 30 seconds but did chip front teeth, had patient sit for additional 30 minutes for observation. got an emergency visit to dentist for repair. Follow up call indicated patient felt fine though tired at home
I had some minor bruising but the most particular thing was these small red dots that appeared on my arm at the injection site. Probably a total of eight small red dots size of a little bigger of a pen tip. Appear to be blood pooling. They were in a straight line that seemed to outline the Band-Aid so it really stood out as strange. No pain nothing else going on. Just kind of a weird sight.
Administered Pediatric Vaccine dosage 10 mcg to a 12 year old instead of 12+ Pfizer (Comirnaty) 30 mcg.
Patient stated that he developed a rash shortly after getting his first dose of the Pfizer COVID-19 vaccine. He said that his arm turned red and itchy, but it was nothing similar to hives.
Symptoms of diaphoresis, lightheadedness, and dizzy. No difficulty swallowing or breathing.  Observation extended to 30 minutes in the presence of EMT's. Patient's symptoms resolved within that timeframe. There was no need for hospital transfer.
Within an hour my lips started to swell. I had sores that developed inside my lip. My right arm was very itchy that ratio through my body. That night my lip continued to swell, and my tongue swelled as well and got tingling. The next day my muscle got stiff, and sore and lasted for 2 weeks. At the injection site, my arm had a harden red raised and hot for about 2 weeks. At one point it turned purple. I could not turn my neck because it was so stiff.
Resident received the 2nd does of the vaccine 2 times by mistake. She got the first does on 1/72021 then the 2nd does on 1/28/2021 and got the 2nd dose again on 2/18/2021. In the area where the resident resides there are 2 people with the same name and we believe that caused the confusion. The pharmacy tech called the CDC and Pfizer and they had no recommendations other than to monitor for any side effects.
Shingles; Information has been received from a lawyer referring to a female patient of unknown age. Information about concurrent condition, history condition and concomitant medication was not reported. On 07-APR-2011, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, lot# and expiration date unknown) for routine health maintenance and for its intended purpose: the prevention of shingles. On 25-APR-2011, the patient presented with complaints of a painful rash and was diagnosed with shingles by her primary care physician. The patient's shingles outbreak lasted several weeks causing severe pain and suffering. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using the vaccine. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has incurred and will continue to incur medical expenses and other economic harm as a direct result of zoster vaccine live (ZOSTAVAX). The outcome of the events shingles was considered to be not recovered and causal relationship was assessed as related.    The lawyer considered the events shingles to be disability.   This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2003USA006636:
Left eye twitching. This happened the day after dose #1 as well but didn't think of it as a side effect until it happened again with dose 2
Day 7 after the first vaccine which was on 1/26/21 a blotchy red circle formed around the injection site.  It got larger over the course of a few days. I have less feeling in this area due to my spinal cord injury so it didn?t itch or hurt.  It eventually went away. I received second vaccine dose on 2/23/21 and on 2/25/21 that same circle returned in the same spot even though the new injection site is well above the first one.  Today 2/26/21 it?s larger and more red
I came down with shingles, right side fr.  It is ongoing and may not be related to the Covid-19 vaccine I received, however I report it for your information.   I was vaccinated with Zostavax  on 11/02/2012.
This spontaneous report was received from a pharmacist via field representative refers to unspecified number of patients (maybe 17 or 18) of unknown demographics. Pertinent medical history and drug allergies of the patients were unspecified. On unspecified date between February and March 2015, all these patients received ZOSTAVAX, .65 ml once, subcutaneous. No concomitant medications were reported. These patients experienced redness (mild to moderate) and swelling at injection site. Some of the patients got a bump at site, not described as blister. Reporting pharmacist stated that the symptoms dissipated over time and there were no details on any treatment. Outcome of the events were recovering. Causality assessment was not provided. Additional information has been requested.
On the day, my left arm and had a rushing tingling feeling and increased heart rate and a panic and anxiety from the feeling. Soreness, chills and temperature. 10pm, I had nausea started. 1am with fever 101.6 and back to bed. May 2 had severe dizziness and like I was on a boat, a disequilibrium. Feeling dizziness and nausea, dizziness continued for 4 weeks. Vit C middle of May on 21 May and 4 days after my symptoms went away complete. 6 Jun I woke, and the dizziness came back and ringing in my ear and hard to hear on my left ear and there is still ringing. I am still dizzy and off balance.
swollen lymph node in neck area; arm sensitivity; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sensitivity) and LYMPHADENOPATHY (swollen lymph node in neck area) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032MZ0A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm sensitivity). On 19-Mar-2021, the patient experienced LYMPHADENOPATHY (swollen lymph node in neck area). At the time of the report, PAIN IN EXTREMITY (arm sensitivity) and LYMPHADENOPATHY (swollen lymph node in neck area) outcome was unknown. Not Provided          No concomitant and treatment products reported. Action taken with mRNA-1273 in response to the events was Not Applicable.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 26-JUL-2016, the patient was vaccinated with a dose of improperly stored PROQUAD (lot # M010478, expiration date: 01-SEP-2017; dose and route were not provided). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
A few days after receiving the vaccine I started to develop a rash forming all over my face and started to work it's way up to the scalp. There were just huge chunks of dry skin falling off my body. I started to get very stressed and decide to go to the physician's office where they prescribed a cream and I also tried to use over the counter creams they were just not working. The rash spread all over my body and it was getting so painful to even walk.
My water broke the next morning (April 9) after having the second dose of moderna on April 8th. I was at 36 weeks and 1 day in my pregnancy. I had just scheduled a c-section for April 30th on the day I got the injection. So my water breaking the next morning was quite a shock. We were able to do a c-section. He weighed 6 pounds and 3 ounces. He had hypoglycemia and we ended up having to do a glucose pump.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2017, a healthcare provider at a healthcare facility administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In 2017, the patient was treated by a healthcare provider (at an eye surgery and laser center/surgical center)(treatment not further specified) for shingles. The patient was diagnosed with shingles and or other zoster-related injuries after and despite being inoculated with the zoster vaccine live (ZOSTAVAX) vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (not further specified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
She went to the ER  august 27 with shortness of breath and she was having  atrial fibrillation with congestive heart failure . September 18 th  she was admitted for the same thing  , then went to a rehabilitation facility to get stronger.  She same home October 12 and was having gastrointestinal bleeding and  eventually admitted again and ultimately passed away. We think the vaccine made her sicker.  She didn?t have atrial fibrillation  before the vaccine . The dr put her on a blood thinner because of the atrial fibrillation.  It caused the bleeding  and  possibly the stroke as well.
Large painless bruised area where injected. Since then constantly have purple " bruises" like bleeding under skin. on arms and legs.
Severe HA, chills, neck and back pain, and nausea that for 36 hours
out break on his waist so his waist is really very swollen; out break on his waist so his waist is really very swollen; Nervous; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the parent.  A 58 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing), notes: Verbatim: Asthma; "Psoriasis" (unspecified if ongoing), notes: Verbatim: Psoriasis; "voice incomprehensive" (unspecified if ongoing), notes: He got some (voice incomprehensive),. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1 of Pfizer COVID-19 vaccine.), for COVID-19 Immunization.  The following information was reported: RASH (non-serious), SWELLING (non-serious), outcome "unknown" and all described as "out break on his waist so his waist is really very swollen"; NERVOUSNESS (non-serious), outcome "unknown", described as "Nervous".  Additional information: Start date ,NDC number , Expiry date  and UPC number of COVID-19 Vaccine was unknown. No lot number was reported. The parent did not know how much her son weighed and  mentioned that after receiving Pfizer COVID-19 vaccine, her son had some side effects. So,she was already asking assistance to different doctors in regards with the swollen waist and she was reporting a side effect that her son got form the COVID-19 vaccine. He was so nervous that she could not say one talk to him.Reporter seriousness for out break on his waist so his waist is really very swollen and nervous was unspecified.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pfizer COVID-19 vaccine EUA: Administration error- booster dose given too soon. Patient received 3 doses of Pfizer COVID-19 vaccine on 5/13/2021, 6/3/2021 and 10/27/2021 respectively. There was not 6 months between 2nd and 3rd dose.  This appears to be an oversight. The dose was given before 12/3/2021. No adverse effects reported.
Child developed itchy flat red rash over face a upper trunk. No rash or swelling at injection site. Pulling at ears, c/o chest pain HR 118, R 22 B/P 88/58. Had vomiting x 3. Given BENADRYL 1 mg IM x 1 sent to hospital.
24 hrs after vaccine administration developed diarrhea green and foamy > 10 daily lasted 1 week after stool's decreased in frequency developed "red streaks" on diaper.
At first high fever an inconsolable crying. Then his left thigh swelled up so large I thought I'd have to go to the emergency room. In the following weeks he lost his ability to speak, started drooling nonstop, only screamed and lost his ability to make eye contact. He then stopped playing with toys or acknowledging his sister, he stopped mimicking sounds and facial movements for play. Shortly after this he stopped waving,  clapping or acknowledging any sounds. He began walking around the house in his own world unaware of anyone. Simply licking the walls and screaming with nothing to help. Within weeks our nuero typical son had become cognitively impaired and
This spontaneous report as received from a registered nurse refers to multiple unspecified patients who were administered vaccines which were stored improperly. This report refers to the patients who on unknown dates were vaccinated with GARDASIL that were stored improperly. No adverse effects reported. Follow up information was from the same registered nurse who stated that patient identifiers and dates of administration were unavailable at this time; however, lot numbers and expiration dates were available for the vaccines that were improperly stored: GARDASIL lot # J013324, expiration date: 12-FEB-2016. This is one of several reports received from the same reporter. Additional information has been requested.
Slight headache; Nauseated; Arm is sore; Temperature as high as 100.4; This is a spontaneous report from a contactable consumer or other non hcp. A 88-years-old female patient received second dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: ER8727) via an unspecified route of administration in Arm Right on 25Mar2021 09:30 (age at vaccination: 88 Years) as DOSE 2, SINGLE for covid-19 immunisation. Patient didn't receive other vaccines within 4weeks prior to vaccination. Medical history included hypertension from an unknown date and unknown if ongoing Diagnosed when she was 34 years old, atrial fibrillation from Feb2021 to an unknown date Diagnosed about a month ago. Patient previously received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6198) via unspecified route of administration on 04Mar2021 (age at vaccination: 88 Years) as DOSE 1, SINGLE for covid-19 immunisation. The patient experienced temperature as high as 100.4 on 25Mar2021, slight headache on 26Mar2021, nauseated on 26Mar2021, arm is sore on 26Mar2021. The patient underwent lab tests and procedures which included body height: shrunk a little on unspecified date, body temperature: 100.4 on Mar2021, body temperature: 98 on Mar2021. The outcome of the events pyrexia, nausea was not recovered, the outcome of the events headache, pain in extremity was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
had lethargy & non-responsiveness, hypotonic for approx 36 hrs p/vax;
ITP immune thrombocytopenic purpura  BRUISING, BLOOD SPOTS, BLEEDING GUMS, BLEEDING NOSE, BLOOD IN TEARS  RECIEVED IVIG
My son was perfectly healthy and was hitting all his milestones appropriately until he was given the MMR vaccine at 6 months of age. He then stopped hitting milestones and regressed in his development. He was diagnosed with Pervasive Developmental Disorder at age 3 and officially diagnosed with Autism at age 5. He was non-verbal until age 6.